CLINICAL_TRIALS
trial_result
· 2025-04-03
Clinical Trial Update: Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes [EARLY_Phase 1]
Summary
An early-phase Phase 1 trial evaluating riboflavin for reducing muscle soreness in ultra-marathon athletes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steven Moore | Conditions: Muscle Soreness | EARLY_Phase 1 | Status: COMPLETED